Stelo
-
Press Releases
ŌURA Redefines Metabolic Health Tracking with Two New AI-Driven Features: Meals and Glucose
ŌURA, maker of the world’s leading smart ring, today announced a significant expansion of its product experience through the introduction of two new metabolic health features, Meals and Glucose. With these new product capabilities, ŌURA takes a holistic, AI-driven approach to metabolic health by combining meal insights with glucose data from Stelo by Dexcom, the first FDA-cleared glucose biosensor available…
Read More » -
Press Releases
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription4 at Stelo.com. “In a world where GLP-1 use is becoming increasingly more common, glucose biosensors like Stelo can help make those medications more effective.12”Post this Stelo is…
Read More » -
Press Releases
Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom – the first glucose biosensor that doesn’t require a prescription. There are approximately 25 million people in the U.S. living with Type 2 diabetes who do not use insulin and who can benefit from continuous glucose…
Read More »